Genetics of adrenocortical tumors: Gatekeepers, landscapers and conductors in symphony

Trends in Endocrinology and Metabolism

Volumn 14, Issue 9, 2003, Pages 404-410

  Stratakis, Constantine A ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INHIBIN; MOLECULAR MARKER; NEUROFIBROMIN;

ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CELL; ADRENAL CORTEX TUMOR; CANCER GENETICS; CANCER MODEL; CARCINOGENESIS; CUSHING SYNDROME; CYTOGENETICS; DIABETES MELLITUS; GENE; GENE CONTROL; GENE FUNCTION; GENE MUTATION; GNAS1 GENE; HUMAN; HYPERTENSION; IGF2 GENE; IMMUNOHISTOCHEMISTRY; MOLECULAR GENETICS; NONHUMAN; OBESITY; ONCOGENE; PENETRANCE; PRECANCER; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; PRKAR1A GENE; REVIEW; TP53 GENE; TUMOR SUPPRESSOR GENE;

EID: 0242696220     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2003.08.005     Document Type: Review

References (82)

1. Bornstein, S. et al. (1999) Adrenocortical tumors: recent advances in basic concepts and clinical management. Ann. Intern. Med. 130, 759-771
2. Koch, C.A. et al. (2002) The molecular pathogenesis of hereditary and sporadic adrencortical and adrenomedullary tumors. J. Clin. Endocrinol. Metab. 87, 5367-5384
3. Beuschlein, F. et al. (1994) Clonal composition of human adrenocortical neoplasms. Cancer Res. 54, 4927-4932
4. Lin, S.R. et al. (1994) Mutations of the p53 gene in human functional adrenal neoplasms. J. Clin. Endocrinol. Metab. 78, 483-491
5. Kjellman, M. et al. (1996) Genetic aberrations in adrenocortical tumors detected using comparative genomic hybridization correlate with tumor size and malignancy. Cancer Res. 56, 4219-4223
6. Zhao, J. et al. (1999) Analysis of genomic alterations in sporadic adrenocortical lesions. Gain of chromosome 17 is an early event in adrenocortical tumorigenesis. Am. J. Pathol. 155, 1039-1045
7. Figureido, B.C. et al. (1999) Comparative genomic hybridization (CGH) analysis of adrenocortical tumors in childhood. J. Clin. Endocrinol. Metab. 84, 1116-1121
8. Sidhu, S. et al. (2002) Comparative genomic hybridization analysis of adrenocortical tumors. J. Clin. Endocrinol. Metab. 87, 3467-3474
9. Shono, T. et al. (2002) Analysis of numerical chromosomal aberrations in adrenal cortical neoplasms by fluorescence in situ hybridization. J. Urol. 168, 1370-1373
10. Roshani, L. et al. (2002) Aberrations of centrosomes in adrenocortical tumors. Int. J. Oncol. 20, 1161-1165
11. Gicquel, C. et al. (2001) 17p13 LOH, 11p15 LOH and overexpression of the IGF-II gene: prognostic implications in a large series of sporadic adrenocortical tumors. Cancer Res. 61, 6762-6767
12. Stratakis, C.A. et al. (1996) Cytogenetic and microsatellite alterations in tumors from patients with the syndrome of myxomas, spotty skin pigmentation, and endocrine overactivity (Carney complex). J. Clin. Endocrinol. Metab. 81, 3607-3614
13. Kjellman, M. et al. (1999) Genotyping of adrenocortical tumors: very frequent deletions of the MEN1 locus in 11q13 and of a 1cM region in 2p16. J. Clin. Endocrinol. Metab. 84, 730-736
14. Gutmann, D.H. et al. (1994) Loss of neurofibromin in adrenal gland tumors from patients with neurofibromatosis type I. Genes Chromosomes Cancer 10, 55-58
15. Schulte, K-M. et al. (1999) MEN I gene mutations in sporadic adrenal adenomas. Hum. Genet. 105, 603-610
16. Heppner, C. et al. (1999) MEN1 gene analysis in sporadic adrenocortical neoplasms. J. Clin. Endocrinol. Metab. 84, 216-219
17. Risbridger, G.P. et al. (2001) Activins and inhibins in endocrine and other tumors. Endocr. Rev. 22, 836-858
18. Matzuk, M.M. et al. (1996) Transgenic models to study the roles of inhibins and activins in reproduction, oncogenesis, and development. Recent Prog. Horm. Res. 51, 123-154
19. Matzuk, M.M. et al. (1994) Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 91, 8817-8821
20. Kananen, K. et al. (1996) Gonadectomy permits adrenocortical tumorigenesis in mice transgenic for the mouse inhibin α-subunit promoter/simian virus 40 T-antigen fusion gene: evidence for negative autoregulation of the inhibin α-subunit gene. Mol. Endocrinol. 10, 1667-1677
21. Arola, J. et al. (2000) Expression of inhibin α in adrenocortical tumors reflects the hormonal status of the neoplasm. J. Endocrinol. 165, 223-229
22. McCluggage, W.G. et al. (1998) Immunohistochemical staining of normal, hyperplastic, and neoplastic adrenal cortex with a monoclonal antibody against alpha inhibin. J. Clin. Pathol. 51, 114-116
23. Pelkey, T.J. et al. (1998) The α subunit of inhibin in adrenal cortical neoplasia. Mod. Pathol. 11, 516-524
24. Vanttinen, T. et al. (2002) Expression of activin/inhibin receptor and binding protein genes and regulation of activin/inhibin peptide secretion in human adrenocortical cells. J. Clin. Endocrinol. Metab. 87, 4257-4263
25. Varley, J.M. et al. (1999) Are there low-penetrance TP53 alleles? Evidence from childhood adrenocortical tumors. Am. J. Hum. Genet. 65, 995-1006
26. Ribeiro, R.C. et al. (2001) An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. Proc. Natl. Acad. Sci. U. S. A. 98, 9330-9335
27. Latronico, A.C. et al. (2001) An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors. J. Clin. Endocrinol. Metab. 86, 4970-4973
28. Di Giammarino, E.L. et al. (2002) A novel mechanism of tumorigenesis involving pH-dependent destabilization of a mutant p53 tetramer. Nat. Struct. Biol. 9, 12-16
29. Hainaut, P. (2002) Tumor-specific mutations in p53: the acid test. Nat. Med. 8, 21-23
30. Reincke, M. (1998) Mutations in adrenocortical tumors. Horm. Metab. Res. 30, 447-455
31. Kirschner, L.S. et al. (2000) Mutations of the gene encoding the protein kinase A type I-α regulatory subunit in patients with the Carney complex. Nat. Genet. 26, 89-92
32. Kirschner, L.S. et al. (2000) Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the Carney complex. Hum. Mol. Genet. 9, 3037-3046
33. Stratakis, C.A. (2002) Mutations of the gene encoding the protein kinase A type I-α regulatory subunit (PRKAR1A) in patients with the 'complex of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas' (Carney complex). Ann. N. Y. Acad. Sci. 968, 3-21
34. Stratakis, C.A. et al. (2001) Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J. Clin. Endocrinol. Metab. 86, 4041-4046
35. Groussin, L. et al. (2002) Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease (PPNAD). J. Clin. Endocrinol. Metab. 87, 4324-4329
36. Cho-Chung, Y.S. and Clair, T. (1993) The regulatory subunit of cAMP-dependent protein kinase as a target for chemotherapy of cancer and other cellular dysfunctional-related diseases. Pharmacol. Ther. 60, 265-288
37. Sarlis, N.J. et al. (1997) Primary pigmented nodular adrenocortical disease: reevaluation of a patient with carney complex 27 years after unilateral adrenalectomy. J. Clin. Endocrinol. Metab. 82, 1274-1278
38. Stratakis, C.A. et al. (1999) Paradoxical response to dexamethasone in the diagnosis of primary pigmented nodular adrenocortical disease. Ann. Intern. Med. 131, 585-591
39. Sandrini, F. et al. (2002) Regulatory subunit type I- of protein kinase A (PRKAR1A): a tumor-suppressor gene for sporadic thyroid cancer. Genes Chromosomes Cancer 35, 182-192
40. Sandrini, F. et al. (2002) PRKAR1A, one of the Carney complex genes, and its locus (17q22-24) are rarely altered in pituitary tumors outside the Carney complex. J. Med. Genet. 39, E78
41. Kaltsas, G.A. et al. (2002) Sequence analysis of the PRKAR1A gene in sporadic somatotroph and other pituitary tumors. Clin. Endocrinol. (Oxf) 57, 443-448
42. Bertherat, J., et al. Molecular and functional Analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression. Cancer Res., (in press)
43. Groussin, L. et al. (2002) Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with Carney complex and/or primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysiology: augmented PKA signaling is associated with adrenal tumorigenesis in PPNAD. Am. J. Hum. Genet. 71, 1433-1442
44. Kirschner, M.A. and Lipsett, M.B. (1964) Nodular cortical hyperplasia of adrenal glands with clinical and pathological features suggesting adrenocortical tumor. J. Clin. Endocrinol. Metab. 24, 947-955
45. Lacroix, A. et al. (2001) Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome. Endocr. Rev. 22, 75-110
46. Bourdeau, I. and Stratakis, C.A. (2002) Cyclic AMP-dependent signaling aberrations in macronodular adrenal disease. Ann. N. Y. Acad. Sci. 968, 240-255
47. Bourdeau, I. et al. (2001) Aberrant membrane hormone receptors in incidentally discovered bilateral macronodular adrenal hyperplasia with subclinical Cushing's syndrome. J. Clin. Endocrinol. Metab. 86, 5534-5540
48. Findlay, J.C. et al. (1993) Familial adrenocorticotropin-independent Cushing's syndrome with bilateral macronodular adrenal hyperplasia. J. Clin. Endocrinol. Metab. 76, 189-191
49. Minami, S. et al. (1996) ACTH independent Cushing's syndrome occurring in siblings. Clin. Endocrinol. (Oxf) 44, 483-488
50. Nies, C. et al. (2002) Familial ACTH-independent Cushing syndrome with bilateral macronodular adrenal hyperplasia clinically affecting only female family members. Exp. Clin. Endocrinol. Diabetes 110, 277-283
51. Kirk, J.M. et al. (1999) Cushing's syndrome caused by nodular adrenal hyperplasia in children with McCune-Albright syndrome. J. Pediatr. 134, 789-792
52. Boston, B.A. et al. (1994) Activating mutation in the stimulatory guanine nucleotide-binding protein in an infant with Cushing's syndrome and nodular adrenal hyperplasia. J. Clin. Endocrinol. Metab. 79, 890-893
53. Fragoso, M.C. et al. (2003) Cushing's syndrome secondary to adrenocorticotropin-independent macronodular adrenocortical hyperplasia due to activating mutations of GNAS1 gene. J. Clin. Endocrinol. Metab. 88, 2147-2151
54. Lacroix, A. et al. (1992) Gastric inhibitory polypeptide-dependent cortisol hypersecretion-a new cause of Cushing's syndrome. N. Engl. J. Med. 327, 974-980
55. Reznik, Y. et al. (1992) Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide. N. Engl. J. Med. 327, 981-986
56. Mircescu, H. et al. (2000) Are ectopic or abnormal membrane hormone receptors frequently present in adrenal Cushing's syndrome? J. Clin. Endocrinol. Metab. 85, 3531-3536
57. Groussin, L. et al. (2002) The ectopic expression of the gastric inhibitory peptide receptor is frequent in ACTH-independent macronodular adrenal hyperplasia, but rare in benign adrenal adenomas. J. Clin. Endocrinol. Metabol. 87, 1980-1985
58. Bugalho, M.J. et al. (2000) Presence of a Gsα mutation in an adrenal tumor expressing LH/hCG receptors and clinically associated with Cushing's syndrome. Gynecol. Endocrinol. 14, 50-54
59. Bourdeau, I. et al. (2002) Differential gene expression in sporadic macronodular adrenal hyperplasia compared to normal adrenals by microarrays: dissecting the genetics of adrenocortical tumorigenesis. Am. J. Hum. Genet. 71, S189
60. Willenberg, H. et al. (1998) Cytokine-induced ACTH-independent Cushing syndrome. N. Engl. J. Med. 339, 27-31
61. Marx, C. et al. (1997) Relevance of major histocompatibility complex class II expression as a hallmark for the cellular differentiation in the human adrenal cortex. J. Clin. Endocrinol. Metab. 82, 3136-3142
62. Sasano, H. et al. (1994) Transforming growth factor and epidermal growth factor receptor expression in normal and diseased human adrenal cortex by immunohistochemistry and in situ hybridization. Mod. Pathol. 7, 741-747
63. Komminoth, P. et al. (1995) Overlapping expression of immunohistochemical markers and synaptophysin mRNA in pheochromocytomas and adrenocortical carcinomas. Implications for the differential diagnosis of adrenal gland tumors. Lab. Invest. 72, 424-430
64. Stratakis, C.A. et al. (1999) Synaptophysin immunoreactivity in primary pigmented nodular adrenocortical disease: neuroendocrine properties of tumors associated with Carney complex. J. Clin. Endocrinol. Metab. 84, 1122-1128
65. Yamakita, N. et al. (1997) Adrenocorticotropin-independent macronodular adrenocortical hyperplasia associated with multiple colon adenomas/carcinomas which showed a point mutation in the APC gene. Intern. Med. 36, 536-542
66. Wakatsuki, S. et al. (1998) Adrenocortical tumor in a patient with familial adenomatous polyposis: a case asociated with a complete inactivating mutation of the APC gene and unusual histologic features. Hum. Pathol. 29, 302-306
67. Carney, J.A. (1999) Gastric stromal sarcoma, pulmonary chondroma, and extra-adrenal paraganglioma (Carney Triad): natural history, adrenocortical component, and possible familial occurrence. Mayo Clin. Proc. 74, 543-552
68. Carney, J.A. and Stratakis, C.A. (2002) Familial paraganglioma and gastric stromal sarcoma: a new syndrome distinct from the Carney triad. Am. J. Med. Genet. 108, 132-139
69. Kinzler, K.W. and Vogelstein, B. (1996) Lessons from hereditary colorectal cancer. Cell 87, 159-170
70. Bernard, M.H. et al. (2003) A case report in favor of a multistep adrenocortical tumorigenesis. J. Clin. Endocrinol. Metab. 88, 998-1001
71. Bhatia, V. et al. (1993) Adrenal tumor complicating untreated 21-hydroxylase deficiency in a 5 1/2-year-old boy. Am. J. Dis. Child. 147, 1321-1323
72. Eng, C. (2000) Familial papillary thyroid cancer-many syndromes, too many genes? J. Clin. Endocrinol. Metab. 85, 1755-1757
73. Bardeesy, N. et al. (2002) Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation. Nature 419, 162-167
74. McLaughlin, M.E. and Jacks, T. (2002) Thinking beyond the tumor cell: Nf1 haploinsufficiency in the tumor environment. Cancer Cell 1, 408-410
75. Matyakhina, L. et al. (2002) Protein kinase A and chromosomal stability. Ann. N. Y. Acad. Sci. 968, 148-157
76. Eng, C. (1999) RET proto-oncogene in the development of human cancer. J. Clin. Oncol. 17, 380-393
77. Bordeaux, M.C. et al. (2000) The RET proto-oncogene induces apoptosis: a novel mechanism for Hirschsprung disease. EMBO J. 19, 4056-4063
78. Macleod, K. (2000) Tumor suppressor genes. Curr. Opin. Genet. Dev. 10, 81-93
79. Vogelstein, B. (2000) Complexity in cancer. Nature 408, 307-311
80. Playford, R.J. (2001) Landscaper seeks remunerative position. Gut 48, 594-595
81. Giordano, T. et al. (2003) Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis. Am. J. Pathol. 162, 521-531
82. Grumbach, M.M. et al. (2003) Management of the clinically inapparent adrenal mass ('incidentaloma'). Ann. Intern. Med. 138, 424-429